Conjugated linoleic acid and obesity control : efficacy and mechanisms

  1. (PDF, 331 KB)
  2. Get@NRC: Conjugated linoleic acid and obesity control : efficacy and mechanisms (Opens in a new window)
DOIResolve DOI:
AuthorSearch for: ; Search for:
Journal titleInternational Journal of Obesity
Pages941955; # of pages: 15
SubjectNutrition disorder; Unsaturated fatty acid; Nutritional status; Animal; Human; Lipids; Biological effect; Deposition; Fat; Body weight; n-6 fatty acid; Linoleic acid; Obesity; animals; conjugated linoleic acid; fat deposition; mechanisms; humans; Acide gras insaturé; Etat nutritionnel; Homme; Lipide; Effet biologique; Dépôt; Matière grasse; Poids corporel; Acide gras n-6; Linoléique acide; Obésité
AbstractObesity is associated with high blood cholesterol and high risk for developing diabetes and cardiovascular disease. Therefore, management of body weight and obesity are increasingly considered as an important approach to maintaining healthy cholesterol profiles and reducing cardiovascular risk. The present review addresses the effects of conjugated linoleic acid (CLA) on fat deposition, body weight and composition, safety, as well as mechanisms involved in animals and humans. Animal studies have shown promising effects of CLA on body weight and fat deposition. The majority of the animal studies have been conducted using CLA mixtures that contained approximately equal amounts of trans-10, cis-12 (t10c12) and cis-9, trans-11 (c9t11) isomers. Results of a few studies in mice fed CLA mixtures with different ratios of c9t11 and t10c12 isomers have indicated that the t10c12 isomer CLA may be the active form of CLA affecting weight gain and fat deposition. Inductions of leptin reduction and insulin resistance are the adverse effects of CLA observed in only mice. In pigs, the effects of CLA on weight gain and fat deposition are inconsistent, and no adverse effects of CLA have been reported. A number of human studies suggest that CLA supplementation has no effect on body weight and insulin sensitivity. Although it is suggested that the t10c12 CLA is the antiadipogenic isomer of CLA in humans, the effects of CLA on fat deposition are marginal and more equivocal as compared to results observed in animal studies. Mechanisms through which CLA reduces body weight and fat deposition remain to be fully understood. Proposed antiobesity mechanisms of CLA include decreased energy/food intake and increased energy expenditure, decreased preadipocyte differentiation and proliferation, decreased lipogenesis, and increased lipolysis and fat oxidation. In summary, CLA reduces weight gain and fat deposition in rodents, while produces less significant and inconsistent effects on body weight and composition in pigs and humans. New studies are required to examine isomer-specific effects and mechanisms of CLA in animals and humans using purified individual CLA isomers.
Publication date
PublisherNature Publishing Group
AffiliationNational Research Council Canada
Access conditionavailable
Peer reviewedYes
NRC publication
This is a non-NRC publication

"Non-NRC publications" are publications authored by NRC employees prior to their employment by NRC.

NRC number54693
NPARC number9148606
Export citationExport as RIS
Report a correctionReport a correction
Record identifierb0305682-1f67-4fba-8e3d-22a7208626c6
Record created2009-10-03
Record modified2016-05-09
Bookmark and share
  • Share this page with Facebook (Opens in a new window)
  • Share this page with Twitter (Opens in a new window)
  • Share this page with Google+ (Opens in a new window)
  • Share this page with Delicious (Opens in a new window)
Date modified: